2021
DOI: 10.1042/bsr20202907
|View full text |Cite
|
Sign up to set email alerts
|

Development of a prognostic model based on an immunogenomic landscape analysis of medulloblastoma

Abstract: Medulloblastoma (MB) is one of the most common central nervous system tumors in children. At present, the vital role of immune abnormalities has been proved in tumorigenesis and progression. However, the immune mechanism in MB is still poorly understood. In the present study, 51 differentially expressed immune-related genes (DE-IRGs) and 226 survival associated immune-related genes (Sur-IRGs) were screened by an integrated analysis of multi-array. Moreover, the potential pathways were enriched by functional an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 71 publications
0
4
0
Order By: Relevance
“…As mentioned above, inositols can impair oncogenic signalling using several mechanisms including inhibition of the PI3K/Akt pathway 43 . Notably, this has already been recognised in medulloblastoma as one of the relevant oncogenic pathways contributing to the disease 53 and, accordingly, a selective pan-class I PI3K inhibitor namely BKM120 has been revealed as a potential novel therapy for MB 54 . Thus, in our MYC-driven cell models OTX-015 treatment may upregulate myo-inositol production, counteracting PI3K/Akt/mTOR signalling and eventually triggering tumour cell death.…”
Section: Discussionmentioning
confidence: 99%
“…As mentioned above, inositols can impair oncogenic signalling using several mechanisms including inhibition of the PI3K/Akt pathway 43 . Notably, this has already been recognised in medulloblastoma as one of the relevant oncogenic pathways contributing to the disease 53 and, accordingly, a selective pan-class I PI3K inhibitor namely BKM120 has been revealed as a potential novel therapy for MB 54 . Thus, in our MYC-driven cell models OTX-015 treatment may upregulate myo-inositol production, counteracting PI3K/Akt/mTOR signalling and eventually triggering tumour cell death.…”
Section: Discussionmentioning
confidence: 99%
“…It has been shown that polysaccharides modulated the immune system by regulating immune cells [ 23 ]. Macrophage activation played an important role in immunological activity, and this activation secretes cytokines such as TNF-α, interleukin-1 (IL-1), IL-6, and interferon (IFN)-α/β participated in the regulation of cellular defense [ 24 ]. TNF-α is a representative cytokine that supports the immune system and induces inflammation.…”
Section: Discussionmentioning
confidence: 99%
“…Since it was discovered twenty years ago, TNF has been known as an anti-cancer agent while also having a multifunctional impact on lipid metabolism, coagulation, insulin resistance, and endothelial function [49]. Cells can receive both survival and death signals from members of the TNFR superfamily [50]. Tumor necrosis factor alpha (TNF-α) is a versatile cytokine that plays a crucial role in regulating numerous signaling pathways associated with inflammation, immunity, apoptosis (cell death), anti-apoptosis (cell survival), and even the development of tumors [51].…”
Section: Enrichment Analysis Of Go and Kegg Pathways On The Basis Of ...mentioning
confidence: 99%